Patent details

EP3670528 Title: SCLEROSTIN BINDING AGENTS

Basic Information

Publication number:
EP3670528
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP192116234
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SCLEROSTIN BINDING AGENTS
French Title of Invention:
AGENTS DE LIAISON DE LA SCLÉROSTINE
German Title of Invention:
SCLEROSTINBINDENDE WIRKSTOFFE
SPC Number:

Dates

Filing date:
28/04/2006
Grant date:
08/09/2021
EP Publication Date:
24/06/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/09/2021
EP B1 Publication Date:
08/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/04/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/09/2021
 
 

Name:
Amgen, Inc
Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Name:
UCB Pharma S.A.
Address:
Allée de la Recherche 60, 1070 Brussels, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
23/11/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LATHAM, John
Address:
United States (US)

2

Name:
WINTERS, Aaron George
Address:
United States (US)

3

Name:
ROBINSON, Martyn Kim
Address:
United Kingdom (GB)

4

Name:
HOFFMAN, Kelly Sue
Address:
United States (US)

5

Name:
LU, Hsieng Sen
Address:
United States (US)

6

Name:
SHEN, Wenyan
Address:
United States (US)

7

Name:
POPPLEWELL, Andy
Address:
United Kingdom (GB)

8

Name:
WINKLER, David
Address:
United States (US)

9

Name:
GRAHAM, Kevin
Address:
United States (US)

10

Name:
LAWSON, Alastair
Address:
United Kingdom (GB)

11

Name:
PASZTY, Christopher
Address:
United States (US)

12

Name:
HENRY, Alistair James
Address:
United Kingdom (GB)

Priority

1

Priority Number:
677583 P
Priority Date:
03/05/2005
Priority Country:
United States (US)

2

Priority Number:
776847 P
Priority Date:
24/02/2006
Priority Country:
United States (US)

3

Priority Number:
782244 P
Priority Date:
13/03/2006
Priority Country:
United States (US)

4

Priority Number:
792645 P
Priority Date:
17/04/2006
Priority Country:
United States (US)

5

Priority Number:
411003
Priority Date:
25/04/2006
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/51; C07K 16/18;

Publication

Bulletin

Bulletin Heading:
VB2
Bulletin edition number:
2024/02
Publication date:
05/01/2024
Description:
Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

European Patent Bulletin

1

Issue number:
202136
Publication date:
08/09/2021
Description:
Grant (B1)

2

Issue number:
202326
Publication date:
28/06/2023
Description:
Termination of the opposition

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/04/2025
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
23/11/2021 Power Of Attorney 1
23/11/2021 Outgoing Correspondence 1